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In  previous  reports  (1,  2)  we  demonstrated  that  Toxoplasma  gondii,  an  obligate 
intracellular parasite, is susceptible to oxygen intermediates generated by the partial 
reduction  of molecular  oxygen.  In  a  cell-free  model,  toxoplasmas are  resistant  to 
superoxide anion (O~-) and hydrogen peroxide (H202), but are readily killed by toxic 
products  of O~-H202  interaction,  presumably  hydroxyl  radical  (OH-)  and  singlet 
oxygen (102)  (1). We also implicated these latter two oxygen intermediates as probable 
mediators of the toxoplasmastatic and toxoplasmacidal activity of specifically immune 
peritoneal macrophages (2). 
The present study extends these observations by examining in parallel the antitox- 
oplasma  activity  and  oxidative  capacity  of peritoneal  cells  stimulated  in  vivo  by 
inflammatory and immunologic agents, and in vitro by soluble products of sensitized 
lymphocytes (lymphokines). We have, thus, been able to characterize a  spectrum of 
activated macrophages that differ quantitatively in their production of O~-and H202, 
and their capacity to carry out an intracellular anti-microbial act. Our observations 
also  reemphasize  the  importance  of macrophage  oxygen-dependent  antimicrobial 
mechanisms in both the in vivo and in vitro activated state. 
Materials and Methods 
Parasites.  The virulent RH strain and the nonvirulent Pe strain of Toxoplasma gondii were 
maintained and harvested as previously reported (1). RH strain toxoplasma trophozoites were 
used  to infect  cultivated macrophages, whereas  Pe strain  brain  cysts were used  to produce 
chronically infected toxoplasma immune mice (2). 
Macrophages.  Normal macrophages were obtained from female NCS mice (The Rockefeller 
University, New York).  Toxoplasma-immune macrophages (IM) 1 and immune-boosted mac- 
rophages (IB) were from NCS mice infected 3-8 wk before the Pe brain cysts. Immune-boosted 
mice received  5  ×  106 heat-killed RH toxoplasma trophozoites intraperitoneally 3 d  before 
harvest  (2). Other NCS  mice were injected  intravenously or intraperitoneally with  2  ×  107 
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1596  J. ExP. MED. © The Rockefeller University Press • 0022-1007/80/12/1596/14  $1.00 
Volume 152  December 1980  1596-1609 HENRY W.  MURRAY AND ZANVIL A. COHN  1597 
viable Pasteur type Bacille Calmette-Gu~rin (BCG)  (Trudeau Institute, Saranac Lake, N. Y.) 
or 0.2 ml (1.4 mg) of formalin-killed Co~ynebaeterium  parvum (Coparvax; The Wellcome Research 
Laboratories, Kent, England). Macrophages were harvested 1-3 wk later from intraperitoneal 
BCG-infected mice (3), 3-4 wk later from intravenous BCG-infected mice, and after 1-3 wk for 
(7. parvum-immunized mice.  In  addition, some  animals were boosted  intraperitoneally with 
respective antigen  (2  ×  107  autoclaved  BCG  or  1.4  mg  of C. paroum)  3  d  before  harvest. 
Macrophages were also obtained from NCS mice 4 d after intraperitoneal injection of 1 ml of 
phosphate-buffered saline (PBS)~containing I% proteose peptone (PP), 4% Brewer's thioglycol- 
late (THIO), or 1% heart infusion (HIB) broths, all from Difco Laboratories, Detroit, Mich. 
Additional macrophages (provided by Dr. V. Freedman, The Rockefeller University) were from 
C57BL/6J  mice injected intraperitoneally 3-4 wk before with 2 ×  107 heat-killed BCG, and 
boosted intraperitoneally with dead BCG 4 d before harvest. 
Macrophage Cultivation.  Peritoneal cells were harvested by the method of Cohn and Benson 
(4). 4-5 ×  l0  b cells, suspended in Dulbecco's modified Eagle's medium containing 20% heat- 
inactivated fetal bovine serum (FBS) (HIFBS), 100 U/ml penicillin and 100 #g/ml streptomycin 
(D~HIFBS), were added directly to 12 mm-round glass cover slips. Coverslips were placed in 
35-mm plastic tissue culture dishes (Nunclon,  Roskilde, Denmark)  for toxoplasma infection 
experiments, or in  16-ram wells of tissue culture trays (Costar, Data Packaging, Cambridge, 
Mass.)  for H202  and  O~-assays. After 60  min  at  37°C  in 5%  CO2,  nonadherent  cells were 
removed by washing and cultures were reincubated for up to 72 h before infection or assay in 
D20HIFBS alone or in D20HIFBS plus spleen cell supernates. Fresh media were added daily. 
After 24 h in culture, polymorphonuclear leukocytes accounted for < 1% of adherent cells for all 
macrophage populations. 
P~e~aration of Mitogen- and Antigen-Stimulated Spleen Cell Supernates (Lymphokines).  l0  s cells (1.7 
×  10/ml)  from spleens of (a) toxoplasma immune mice, (b) mice infected intravenously with 
BCG, or (c) normal mice were incubated with  (a)  300/~g  (50/~g/ml)  of toxoplasma frozen- 
thawed antigen (2), (b) 1 ×  10  v (1.7 ×  106/ml) autoclaved BCG, or (c) 3/~g/ml ofconeanavalin 
A  (Con A) (Miles Laboratories Inc., Elkhart, Ind.), respectively, for 48 h at 37°C in 5% CO2. 
In addition, each 6-ml culture contained Dulbecco's medium with  2%  FBS, penicillin, and 
streptomycin.  Control  supernates  consisted  of cultures  of spleen  cells  from  normal  mice 
incubated for 48 h with (a) toxoplasma antigen, (b) autoclaved BCG, or (c) alone, with Con A 
added at the end of the cultivation period. Collected supernates were centrifuged at 500 g for 
20 rain, sterilized by filtration, and stored at -70°C. Just before use, supernates were thawed 
and diluted in D2oHIFBS as follows: toxoplasma 1:20  (5%), BCG 1:8 (12.5%),  and Con A  1:4 
(25%) (5). 
Macrophage Antitoxoplasma Activity.  1 ml of D20HIFBS with  1-2  ×  106 viable toxoplasmas 
was added for 30 min to dishes containing cover slips, followed by washing and reincubation 
in fresh medium. At various intervals, duplicate cover slips were fixed, stained, and counted 
microscopically  as described (2). Killing of intracellular toxoplasmas (microbicidal activity) was 
indicated by a decrease in both the percent of cells infected and in the number of toxoplasmas/ 
100  macrophages,  whereas  failure  of parasites  to  replicate  as judged  by  the  number  of 
toxoplasmas/vacuole 18 h after infection indicated microbistatic activity. Resident macrophages 
from normal mice fail to kill or inhibit the multiplication of viable T. gondii, and  18 h  after 
infection  there  are four  to  five toxoplasmas/vacuole. In  contrast,  IM  macrophages  inhibit 
parasite replication for 24-30 h, and IB cells display potent toxoplasmacidal activity (2). The 
latter  macrophages  also  appear  strikingly activated  morphologically with  circumferential 
spreading, pronounced plasma membrane ruffling, and increased numbers of lysosomes and 
vesicles (2). 
Glucose-Free Medium,  Oxygen Intermediate. Scavengers, and Other Reagents.  Glucose-free medium 
and scavengers including superoxide dismutase (SOD), catalase, mannitol, benzoate, diazabi- 
cyclooctane (DABCO), and  histidine were obtained, prepared, and administered to macro- 
phages as previously reported (2). Glucose oxidase (type V) and xanthine oxidase (milk, 65 mg/ 
ml) were from Sigma Chemical Co., St. Louis, Mo. Xanthine was prepared in 0.05 M potassium 
phosphate buffer (pH 7.8) and EDTA (10  -4 M) at 10  -a M. 
Assays for HzOe and O~ Release.  After various periods of cultivation, cover slips in Costar tray 
wells were thoroughly washed,  and  1.5  ml of Krebs-Ringer phosphate buffer with  5.5  mM 1598  MACROPHAGE OXYGEN-DEPENDENT ANTIMICROBIAL ACTIVITY 
glucose, pH 7.4, was added to each well for 90 min at 37°C (water bath). For HzO= release, the 
1.5-ml reaction mixture contained scopoletin (Sigma Chemical Co.),  10 nmol/ml, horseradish 
peroxidase  (Sigma Chemical Co.,  0.44  purpurogaUin U/ml, and phorbol myristate acetate 
(PMA) (Consolidated Midland Corp., Brewster,  N. Y.),  100 ng/ml (2, 3). For O~-release, each 
1.5 ml contained 80 #M ferricytochrome c (Sigma Chemical Co., type VI) and 100 ng/ml PMA 
(6). For H~O2, the oxidation of scopoletin by H202 catalyzed by horseradish peroxidase was 
assayed  fluorometrically (3). For O~-, the  aspirates were  cleared by centrifugation and  the 
concentration of reduced  cytochrome  c  was  determined spectrophotometrically using the 
extinction coefficient AE~0 ,,~ ---- 2.1 X 104 M -1 cm  -1 (6). In the absence of PMA, there was no 
detectable release  of H202 or O~-. The addition of 25 #g/ml of SOD to the O~- assay reaction 
mixture abolished cytochrome c reduction for all cell types tested.  Cell protein was determined 
by the method of Lowry et al. (7) after treatment of cover slips with 0.5 ml of 0.5 N NaOH. 
Results are expressed  as nanamoles of H202 or O~- released/90 min per microgram of adherent 
cell protein. 
Qualitative Nitroblue Tetrazolium (NBT) Reduction.  Cultivated macrophages were exposed for 
30 rain at 37°C in 5% CO2 to either 2 X l0  s toxoplasmas or 2 X 106 opsonized zymosan particles 
suspended in 1 ml of D20HIFBS containing 0.5 mg/ml of NBT (Sigma Chemical Co.,  grade 
III). Uningested parasites or particles were removed by washing, and cover slips were reincu- 
bated in medium alone for an additional 30 min. Intracellular toxoplasmas and zymosan were 
identified using phase contrast optics and then viewed by bright field microscopy. Macrophages 
were scored as positive if ingested parasites or particles were stained blue-black by precipitated 
formazan, the oxygen-dependent reduction product of NBT (8, 9). 
Results 
In  Vivo-Activated  Macrophages 
OXIDATIVE  CAPACITY  AND  ANTITOXOPLASMA  ACTIVITY.  The  capacity  to  generate 
increased levels of oxidative metabolites appears to underlie the enhanced antitoxo- 
plasma activity of IM and IB macrophages (2). We explored the general applicability 
of this  biochemical-biologic relationship by  examining  12  additional macrophage 
populations activated in vivo by stimuli unrelated to T. gondii. As judged by extracel- 
lular  release  of H20~  (Fig.  1),  there  was  a  close  correlation  (r  --  -0.9)  between 
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FIG.  l.  H20= release vs. toxoplasmastatic activity of resident  normal  (NL), elicited (THIO,  PP, 
[liB),  and immunologically activated (BCG, C. parvum [CP], T. gondii [Toxo]) macrophages. See 
Materials and Methods for injection procedures. To minimize the contribution of any contaminating 
PMN to H202 release, cells were cultivated for 24 h before either triggering with PMA or challenge 
with parasites. Verticle axis indicates the mean number of toxoplasmas/vacuole 18 h after infection. 
After 24 h in culture, only IB were toxoplasmacidal (2). Additional abbreviations: NL +  HKT 
(cells from normal  mice injected intraperitoneally IIPI 3  d  before with 5  X  10  ~ heat-killed 
[ItK] toxoplasmas); BOOST (IP injection of respective antigen 3 d before harvest); and HK BCG 
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macrophage oxidative capacity and the ability to inhibit replication of intracellular 
toxoplasmas. Macrophages elicited by inflammatory agents (THIO, PP, HIB) were 
similar to normal resident cells both in terms of low H2Oz release and the failure to 
display antitoxoplasma activity. In contrast, most macrophage populations activated 
in vivo by variously delivered immunologic microbial stimuli (viable and dead BCG; 
killed  C.  parvum; viable  T.  gondiz) demonstrated  both  enhanced  H202  release  and 
toxoplasmastatic activity.  As  illustrated  in  Fig.  1,  immunologic specificity was not 
required for successful activation of macrophages to inhibit toxoplasma multiplication. 
Intraperitoneal boosting with respective microbial antigen before harvest heightened 
both oxidative and antimicrobial activity, and as previously reported for toxoplasma- 
immune mice (2), converted cells from microbistatic to strongly microbicidal. Intra- 
peritoneal  boosting  of mice  previously injected  intraperitoneally  (but  not  intrave- 
nously) with C. parvum or dead BCG also resulted in toxoplasmacidal activity if cells 
were infected shortly after explanting. At this time, however, up to 20% of adherent 
cells from these mice were polymorphonuclear leukocytes, making interpretation  of 
H202 release difficult.  If first cultivated  for 24  h  before infection,  these boosted  C: 
parvum and  BCG  maerophages  displayed  only  toxoplasmastatic  activity  (Fig.  1). 
Macrophages from nonimmune mice injected intraperitoneally with a  boosting dose 
of dead toxoplasmas 3 d before harvest displayed neither enhanced oxidative capacity 
nor antitoxoplasma activity. 
PRESERVATION  OF  MORPHOLOGIC,  BIOCHEMICAL~  AND  ANTIMICROBIAL PROPERTIES  OF 
THE ACTIVATED STATE BY LYMPHOKINE. If cultivated  in standard  medium alone,  the 
toxoplasmastatic and  toxoplasmacidal activity of IM  and  IB macrophages, respec- 
tively, persists for 48 h  and then is abruptly lost (2).  This loss of activity was closely 
paralleled  by  a  steep  decline  in  oxidative  capacity  such  that  by  72  h  these  cells 
released no more H202 than resident cells from normal mice (Fig. 2). By this time, IM 
and  IB  macrophages  no  longer  appeared  activated  morphologically,  and  closely 
resembled normal cells  (2).  Increased O~" release after PMA triggering also declined 
during 72 h of cultivation  (data not shown). In contrast, daily exposure to as little as 
5% fresh toxoplasma lymphokine maintained  the enhanced  capacity of IM and  IB 
cells to release H202 (Fig. 2) and preserved their in vitro antitoxoplasma activity (Fig. 
3 A). Control supernate failed to prevent the decline in either of these two functional 
markers of macrophage activation. Lymphokine-treated ceils also remained activated 
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FIG. 2.  H202  release by IB (left) and IM (right) macrophages. Cells were cultivated for 3-72 h 
before PMA triggering in medium alone (Q) or medium plus 5% toxoplasma lymphokine (O). 
Media were changed daily. H202 release by cells exposed to 5% control toxoplasma  lymphokine  was 
similar to that  of cells cultivated in standard medium. Results are the means of three to five 
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FIG. 3.  A. Effect of lymphokine on IB (O) and IM (A) macrophage antitoxoplasma activity. Cells 
were cultivated as in Fig. 2 legend in medium alone (open symbols) or medium plus 5% toxoplasma 
lymphokine (closed symbols) for 3-72 h before challenge. Verticle axis indicates the number of 
toxoplasmas/vacuole 18 h after infection. Lymphokine-treated IB cells were toxoptasmacidal when 
challenged at 48 h, but at 72 h were toxoplasmastatic. Control supernate did not prevent the loss of 
[B and IM macrophage antitoxoplasma activity after 48 h. B. Freshly-explanted 3 h cultures of [M 
cells were infected and then cultivated in standard medium (Q), medium plus 5% active toxoptasma 
lymphokine (A), or 5% control [ymphokine (O). Fresh media were added daily. Results for A and 
B are the means of three experiments each performed in duplicate. 
morphologically, showing circumferential  spreading and plasma membrane ruffling. 
Daily  addition  of toxoplasma  lymphokine  after  infection  of freshly  explanted  3-h 
cultures inhibited  the multiplication of the few surviving parasites within IB cells for 
up  to  72  h  (2),  and  partially  reversed  the  loss of IM  macrophage  toxoplasmastatic 
activity (Fig. 3 B). 
In  Vitro-Activated  Macrophages 
EFFECT  OF  LYMPHOKINE  ON  OXIDATIVE CAPACITY AND  ANTITOXOPLASMA ACTIVITY OF 
NORMAL AND  ELICITED MACROPHAGES.  In  vitro  exposure  to  lymphokines  has  been 
reported  to induce normal  human  monocytes and chemically-elicited  (but  not resi- 
dent)  mouse  peritoneal  macrophages  to  inhibit  toxoplasma  replication  (10-13). 
Lymphocyte products can also activate resident or elicited macrophages to kill other 
intracellular  pathogens  such  as  Leishmania  enrietti (14)  and  T~ypanosoma cruzi (5). 
Although  exposure  to  three  separate  lymphokines  (toxoplasma,  BCG,  Con  A)  was 
sufficient  to  morphologically activate  resident  and  PP-elicited  cells  (Fig.  4)  and  to 
augment  their  H~O2  release  (Fig.  5A),  these  cells  failed  to  restrict  toxoplasma 
multiplication.  18 h  after infection of macrophages first preincubated  with lympho- 
kines  for 24-72 h,  there  were four to five toxoplasmas/vacuole.  Further  addition  of 
supernates after infection also failed to induce any inhibitory activity. 
Because products of O~--H202 interaction  (e.g., OH.  and 102 [15-16]) appear to be 
key toxoplasmacidal oxygen intermediates  (2), we next investigated O~-release by in 
vitro-activated macrophages. A  defect in O~-production was not anticipated  because 
most  or all  H~O2  arises  from  the  dismutation  of Of (17).  As  illustrated  in  Fig.  5, 
lymphokine-treated  normal  and  PP-elicited  cells  released  comparable  amounts  of 
H~O2 and O~-, and threefold more O~ than controls after  72 h. 
The possibility  that  ingested  toxoplasmas  fail  to trigger the oxidative  burst  of in 
vitro  activated  macrophages,  and  thus  are  able  to  replicate  by  evading  injurious 
oxygen metabolites  (8), was explored using the qualitative  NBT test  (8,  18).  Normal HENRY  W.  MURRAY  AND  ZANVIL  A.  COHN  1601 
Fio.  4.  Phase contrast micrographs of resident macrophages from normal mice cultivated for 72 
h  in  standard  medium alone  (A)  or  medium plus 5%  toxoplasma lymphokine (B).  Media  were 
changed daily. Appearance of resident and PP-elicited cells after 72 h  of exposure to active Con A 
(25%)  or BCG (12.5%)  supernates was similar to that shown at right. Control supernates failed to 
morphologically activated normal or PP cells. ×  800. 
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FIo.  5.  Enhancement  of normal  macrophage  H~D~  (A)  and  O~  (B)  release  by  lymphokines. 
Resident cells were cultivated for 3-72 h  prior to PMA triggering in medium alone (0) or medium 
plus 5% toxoplasma (x),  12.5%  BCG  (O), or 25% Con A  (A)  supernates. Values for lymphokine- 
stimulated PP-elicited  cells were similar to  those shown in  A  and B. Control  supernates did not 
increase H202 or O~" release above that of cells cultivated in standard medium alone. Results are the 
means of three experiments performed in triplicate. 
cells cultivated in standard medium alone or control supernates responded appropri- 
ately to zymosan particles,  but  failed to  reduce  NBT  after phagocytosis of viable 
toxoplasmas (8)  (Table I  and Fig. 6A). Lymphokine-treated ceils, however, readily 
reduced NBT in response to parasite ingestion (Table I and Fig. 6B), indicating no 
apparent defect in recognition of toxoplasmas. 
ROLE  OF  OXYGEN  INTERMEDIATES  IN  LYMPHOKINE  HIB-INDUCED  ANTITOXOPLASMA AC- 
TIVITY.  In  contrast  to  the  preceding lymphokine experiments,  cocultivation with 
HIB and toxoplasma lymphokine for  18 h  before infection renders  normal macro- 
phages as effective as IM cells in inhibiting parasite multiplication (13).  HIB alone 
has  no  effect.  Although  NBT  reduction  in  response  to  toxoplasma  ingestion  was 1602  MACROPHAGE  OXYGEN-DEPENDENT  ANTIMICROBIAL  ACTIVITY 
TAnL~  I 
Qualitative NBT Reduction by Normal Macrophages 
Treatment:~ 
Percent of cells with precipitated formazan 
1 h after ingestion of* 
Toxoplasmas  Zymosan 
Medium alone  16 :t= 9  85 +  6 
Lymphokines: 
Toxoplasma (5%)  68 :t: 7  93 ±  2 
BCG (12.5%)  70 ±  10  86 -4- 8 
Con A (25%)  64 :t: 6  82 :l: 9 
* Percent of macrophages with intracellular toxoplasmas or zymosan stained 
blue-black by formazan precipitation as in Fig. 6.  Results are the means ± 
SEM  of three to  four experiments, each in duplicate.  Control supernates 
failed to enhance NBT reduction in response to toxoplasma ingestion. Results 
for PP-elicited cells were similar to thee shown in this table. The inclusion 
of SOD  (1 mg/ml) with the parasites or particles decreased the percent of 
cells reducing NBT by a mean of 46% in two experiments. 
:~ Freshly explanted normal macrophages were cultivated in medium alone or 
medium plus lymphokine in the indicated concentrations for 72 h  (media 
changed daily), and were then challenged for 30 rain with either 2  ×  106 
toxoplasmas or 2 ×  106 opsonized zymosan particles suspended in medium 
containing NBT, 0.5 mg/ml. Uningested parasites or particles were removed 
by washing,  and  cultures  were  reincubated  for  an  additional  30  min  in 
medium alone. 
Fro.  6.  Bright  field micrographs demonstrating qualitative NBT  reduction  by  normal  macro° 
phages 1 h after ingestion of toxoplasmas. Cells were cultivated for 72 h in medium alone (A) or 
medium plus 5% toxoplasma lymphokine (B), and then challenged with toxoplasmas suspended in 
0.5  mg/ml NBT as described. Approximately one-third of the control cells  in this field (A) have 
ingested parasites (short arrows), but only one shows a formazan-stained organism (long arrow). In 
contrast,  most  toxoplasmas  ingested  by  lymphokine-stimulated  cells  (B)  have  provoked  NBT 
reduction with formazan precipitation. Extracellular toxoplasmas did not reduce NBT, × 800. Also 
see Table I. 
clearly  enhanced  in  treated  cells  (Table  II),  there  was  only  a  30%  increase  in  O~- 
release  and  no  increase  in  extracellular  H202  release  after  18-24  h  of exposure  to 
HIB-lymphokine  (data  not shown).  However,  HIB  was found  to effectively scavenge 
H202  in both  a  cell-free H202-generating  system  (Fig.  7 A)  and  in PMA-triggered, IB 
macrophages  (Fig.  7 B).  PP  and  THIO  also quenched  H202  production.  In contrast, 
HIB  and  THIO  were  less  effective  scavengers  of enzymatically  generated  O~-  (Fig. 
7 A), and  a  4-h preincubation  with  10 mg/ml  HIB or THIO  reduced  IB O~- release by 
less than  10%  (data not shown). HENRY W.  MURRAY AND ZANVIL A.  COHN 
TABLE  II 
Qualitative NBT Reduction by Normal Macrophages 
Treatment* 
Percent of cells with precipitated forma- 
zan 1 h after ingestion  of:* 
Toxoplasmas  Zymosan 
Medium alone  14 4- 3  76 3= 4 
HIB  15 3= 6  68 3= 9 
Toxoplasma lymphokine  21 3= 6  80 :t= 6 
HIB +  toxoplasma lymphokine  56 3= 8  78 3= 4 
HIB +  control toxoplasma  16 ±  2  60 3= 8 
lymphokine 
* Cells were scored as in the legend to Table I. Results are the means 3= SEM 
of four experiments, each performed in duplicate. 
:~ Freshly explanted normal macrophages were cultivated for 18 h in medium 
alone, medium plus HIB  (8 mg/ml), or toxoplasma lymphokine  (5%), or 
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Fro.  7.  Differential scavenging of H~D2 and O~- by inflammatory agents.  A. THIO or HIB were 
added in the indicated concentrations to either a O~generating (A) xanthine oxidase system  (1) or 
an H~,O2-generating (O) glucose oxidase system (l). O~" production was assayed spectrophotometri- 
cally (39), and HzO2 was assayed  fluorometrically (3). Controls for this representative experiment 
were  O~-, 1.9  nmol/min, and  H202  2.4  nmol/min, at  22°C.  B.  l-d  cultures  of toxoplasma  IB 
macrophages were preincubated  for 4 h  with THIO  (O),  PP  (A), or HIB  (O)  in the indicated 
concentrations, washed thoroughly, and then assayed for H~2 release after PMA triggering. Results 
are the means of three experiments performed in triplicate. Control ,, 0.81 3= 0.11 nmol H~D2/90 
min per microgram of protein. In two additional experiments, overnight preincubation with 8 mg/ 
ml (0.8%) of THIO or HIB reduced IB macrophage HzO2 release to <10% of control values. 
Data  derived  from  exposing  HIB-toxoplasma  lymphokine-activated  cells  to  a 
battery  of oxygen intermediate scavengers, or derived from depriving them of exoge- 
nous  glucose,  are illustrated  in  Table  III.  The  latter procedure  reduces  macrophage 
HzOz  release  (19).  Both  SOD  (for  02-)  and  catalase  (for  HzO2)  effectively reversed 
inhibition of toxoplasma multiplication  (Fig. 8), suggesting a  role for products of their 
interaction  such as OH.  and  102  (15,  16,  20).  OH.  scavengers  (mannitol,  benzoate) 
and  102  quenchers  (DABCO,  histidine)  (20)  were  also  effective in  inhibiting  toxo- 
plasmastatic activity. Thus, similar to our previous observations with in vivo activated 
macrophages  (2),  these  findings  indicate  a  role  for  oxidative  metabolites  in  the 
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TABLE  III 
Effect of Oxygen Intermediate Scavengers and Glucose Deprivation 
Number of toxoplasmas/vacuole 
24 h after infection 
None (control)  1.5 4- 0.2 (6) 
Catalase 2 mg/ml  4.4 4- 0.8 (4) 
SOD 2 mg/ml  2.9 4- 0.4 (4) 
Mannitol 50 mM  3.2 4- 0.5 (3) 
Benzoate 10 mM  2.7 4- 0.6 (3) 
DABCO 1 mM  3.1 4- 0.2 (3) 
Histidine 10 mM  3.4 ±  0.3 (3) 
No glucose  3.5 ± 0.8 (3) 
Freshly explanted normal macrophages were first cultivated for 18 h with HIB 
(8  mg/ml)  and  toxoplasma  lymphokine  (5%), and  were  then  exposed  to 
glucose-free medium or scavengers in the indicated concentrations 3 h before, 
during, and 24 h after infection (2). 5 mM glucose was added back to glucose- 
deprived ceils 2 h after infection  (2). Heated catalase and SOD did not reverse 
parasite inhibition (2). Results are the means "4" SEM of (n) experiments each 
performed in duplicate. 
Fio.  8.  Phase  contrast  micrographs of macrophages  24 h  after infection.  A. Inhibition of toxo- 
plasma replication by normal macrophages cultivated  18 h  before infection with HIB (8 mg/ml) 
and 5% toxoplasma lymphokine. B. Same macrophages after exposure  to exogenous catalase (2 rag/ 
ml) as described  in Table III legend.  ×  1,200. 
Discussion 
By  quantitatively  characterizing  the  oxidative  capacity  of a  wide  spectrum  of in 
vivo- and  in  vitro-stimulated  macrophage  populations,  we  have  provided  firm  evi- 
dence  that  the  enhanced  capacity  to  generate  oxygen  intermediates  is  a  consistent 
marker  that  distinguishes  activated macrophages  from their unstimulated  or inflam- 
matory counterparts.  Moreover,  the close relationship  between  H202  release and  the 
ability  to  act  against  T.  gondii,  an  intracellular  organism  susceptible  to  products  of 
O~--H202  interaction  (1,  2),  illustrates  a  clear  biologic  correlation  for  augmented 
oxidative  metabolism  in  the  antimicrobial  activity of in  vivo immunologically  acti- HENRY W. MURRAY AND ZANVIL A. COHN  1605 
vated macrophages. This latter finding, however, does not necessarily apply to cells 
activated in vitro by lymphokine (see below). 
Although macrophages  elicited by inflammatory agents, such  as THIO,  PP,  or 
starch, spread quickly on glass, phagocytize avidly, and demonstrate certain increased 
metabolic and secretory activities (21), they, like normal cells, fail to display the key 
protective properties of enhanced microbicidal or tumoricidal activity (5, 22-25). Our 
current  findings indicate  that  augmented oxidative  metabolism,  which  has  been 
implicated in both eytocidal processes  (2, 8,  17,  19), is consistently not a  feature of 
normal  or  inflammatory macrophages  when  compared  with  cells  obtained  after 
stimuli such as systemic BCG or toxoplasma infection or immunization with dead 
BCG or C. parvum. Thus, the ability to kill or inhibit intracellular toxoplasmas may be 
a useful in vitro biologic assay system by which both a heightened state of activation 
and  an  augmented oxidative capacity  of in  vivo-stimulated macrophages  can  be 
identified. Indeed, we have yet to encounter an in vivo activated, high HzO2-releasing 
macrophage that does not exert some antitoxoplasma activity. In addition to H202 
and O~-release (6), mononuclear phagocyte oxidative activity has also been assessed 
recently  by  OH.  formation  (26-28).  The  latter  procedure  would  be  particularly 
appropriate  for studies investigating O~-- and  H202-resistant,  but  OH.-susceptible 
targets such as T. gondii (1, 2). 
After 48 h of cultivation in standard medium, IM and IB macrophages spontane- 
ously  lose  their  respective  antitoxoplasma  activities  and  fail  to  restrict  parasite 
replication (2). Because oxygen intermediates appear to mediate this activity (2), it 
was important to observe that macrophage oxidative capacity appropriately declined 
in a  parallel fashion. Nathan et al.  (29) have reported similar results with  T.  cruzi- 
immune cells.  Daily addition of fresh lymphokine, however, preserved both of these 
markers of IM and IB macrophage activation. Previous work has also indicated that 
soluble products of sensitized T  lymphocytes (lymphokines) stimulate a  variety of 
macrophage processes (30, 31), including induction or enhancement of tumoricidal or 
antimicrobial activity (5,  10-14,  24,  32-34)  and  augmented oxidative metabolism 
(29).  In  the  latter study, macrophage release of H20~  correlated  closely with  the 
capacity to kill intracellular trypanosomes (29).  It should be pointed out, however, 
that although lymphokine maintained both the ability of IM and IB cells to release 
increased O~ and H202, and to inhibit parasite replication (toxoplasmastatic activity), 
it did not prevent the eventual loss of IB cells' toxoplasmacidal activity. This finding 
may reflect biologic deficiencies inherent with experimentally prepared lymphokines, 
loss  of macrophage  responsiveness  to  lymphokine, alteration  in  the  generation  or 
delivery of the key toxoplasmacidal oxygen intermediates  (OH.  and  102) (2),  or 
perhaps atrophy of a  synergistic but lymphokine-unresponsive microbicidal mecha- 
nism, 
To explore in vitro activation of macrophages, we attempted to induce resident 
and inflammatory (PP) cells to display antitoxoplasma activity by exposing them to 
mitogen- and antigen-stimulated supernates both before and after infection. In similar 
models,  resident  and  elicited  macrophages  from  normal  mice  can  be  induced  to 
eradicate the intracellular parasites, L.  enrietti (14) and  T.  cruzi  (5).  As reported by 
others  (5,  29),  we  too  found that  lymphokine exposure  morphologically activates 
resident and PP cells and, in parallel, augments O~-and H202 release. However, in 
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to kill or  inhibit  the  replication of intracellular  toxoplasmas.  This  dissociation of 
enhanced oxidative capacity from antimicrobial activity was further emphasized by 
the finding that  in vitro-activated cells released as much O~-and  H202 as in vivo- 
activated macrophages. The latter readily inhibited parasite multiplication (Fig.  1). 
As judged by enhanced intracellular NBT reduction  (8, 9), there was no failure on 
the  part  of lymphokine-treated  cells  to  generate  O~-in  response  to  toxoplasrna 
ingestion. This was  important to investigate because  T. gondii  avoids triggering the 
oxidative respiratory burst of macrophages that permit toxoplasma replication (8). 
The formation of OH. and 102, both of which appear to be toxoplasmacidal (1, 2), 
seems to depend upon the initial interaction of O~-and H~O2 in the presence of trace 
metal  (iron) ions  (15,  16,  20).  Thus, OH-  generation and resultant antitoxoplasma 
activity  would  be  anticipated  by  O~-- and  H202-releasing  in  vitro-activated cells. 
However, as shown in the accompanying report (35), these macrophages contain high 
activity of endogenous O2-and H~O~ scavenging mechanisms  (SOD, eatalase, gluta- 
thione peroxidase) that may interfere with OH. or 102 production within or delivery 
to  the  phagocytic  vacuole.  Such  mechanisms  might  theoretically  not  affect  the 
microbicidal activity of lymphokine-activated, H202-releasing cells toward an H202- 
susceptible parasite such as T. cruzi (29). 
The HIB-lymphokine system, which sufficiently activates normal cells in vitro to 
inhibit toxoplasma replication, permitted assessment of the role of oxygen interme- 
diates in lymphokine-mediated enhancement of antiprotozoal activity. The molecular 
basis underlying the synergistic action of HIB and lymphokines has not been inves- 
tigated, but may be related to the presence of endotoxin (36). Thus, in this system, 
HIB can be replaced by endotoxin (13), as well as THIO (13) or PP, and BCG and 
Con A  supernates can substitute  for toxoplasma lymphokine (H.  Murray. Unpub- 
lished observations).  Although  there was  only a  small  increase in  extracellular O~- 
release and no increase in H202 release after HIB-lymphokine exposure (presumably 
related to the broad scavenging effects of HIB), intracellular oxidative activity was 
clearly enhanced as judged by NBT reduction in response to toxoplasma ingestion 
(8).  Furthermore, exogenous scavengers and quenchers of O~-, H202, OH., and  102 
and glucose deprivation all inhibited the toxoplasmastatic activity of HIB-lympho- 
kine-treated macrophages. These results, which are similar to our previous findings 
with IM and IB cells (2), clearly demonstrate the presence and activity of an oxygen- 
dependent system beyond the production of O2-and H202 in macrophages activated 
in vitro by lymphokines. 
In the course of this study, we also investigated the conflicting data surrounding 
the oxidative capacity of THIO-elicited macrophages that, like normal cells, fail to 
inhibit toxoplasma replication. Johnston et al. (6) reported that, after PMA triggering, 
cultivated THIO macrophages release O~-in amounts comparable with those from 
BCG-infected and  -boosted  mice,  and  10-fold  more  than  normal  resident  macro- 
phages. In contrast, others have found little O~- (37) or H202 (3) release from freshly 
harvested THIO cells in suspension. In our hands, after overnight cultivation these 
macrophages showed intermediate results with a twofold increase in O~-release (0.12 
:1:0.02  nmol//Lg protein), but  no increase in  H202 release compared with  normal 
cells.  THIO  macrophages also  generated fourfold less  O~-than  cells  from IB  mice. 
Interestingly, THIO was found to be a much more effective scavenger of H202 than 
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also recently shown that THIO both inhibits activated macrophages' H202  release 
and antitumor cell activity, an H2Oz-dependent  process. In addition, although the 
intracellular catalase levels of THIO, resident, and IB are comparable after 24 h of 
cultivation, THIO cells contain 50% less SOD and 1.5- to 2.5-fold more gtutathione 
peroxidase (35), thus raising the possibilities  of both diminished formation of H202 
from O2-and/or enhanced H202 decomposition by the reduced glutathione pathway. 
The potentially important role played by the enzymatic oxygen intermediates scav- 
engers, SOD, catalase, and glutathione peroxidase, which are present within both 72. 
gondii and activated macrophages, is examined in the accompanying report. 
Summary 
The  capacity of  15  separate  populations  of mouse  peritoneal  macrophages  to 
generate and release  H202  (an index of oxidative metabolism) was compared with 
their  ability to  inhibit  the  intracellular replication  of virulent  Toxoplasma  gondii. 
Resident macrophages and those elicited by inflammatory agents readily supported 
toxoplasma multiplication and released 4-20× less H202 than macrophages activated 
in  vivo  by  systemic  infection  with  Bacille  Calmette-Gu6rin  or  T.  gondii,  or  by 
immunization with Co~ynebacterium  parvum. Immunologically  activated cells consistently 
displayed both enhanced H202 production and antitoxoplasma activity. Exposure to 
lymphokines generated from cultures of spleen cells from T. gondii immune mice and 
toxoplasma antigen preserved both the antitoxoplasma activity and the heightened 
H202  release  of toxoplasma  immune  and  immune-boosted  macrophages,  which 
otherwise were lost after 48-72 h of cultivation. 
In vitro activation of resident and chemically-elicited cells by 72 h of exposure to 
mitogen- and antigen-prepared lymphokines, conditions that induce trypanocidal (5) 
and  leishmanicidal activity (14), stimulated O2-and  H~O2 release,  and  enhanced 
nitroblue tetrazolium reduction in response to toxoplasma ingestion.  Such treatment, 
however,  failed to confer any antitoxoplasma activity, indicating that intracellular 
pathogens may vary in their susceptibility to macrophage microbicidal mechanisms, 
including specific  oxygen intermediates.  In  contrast, cocultivating normal  macro- 
phages  with  lymphokine plus  heart  infusion broth  for  18  h  rendered  these  cells 
toxoplasmastatic. This in vitro-acquired activity was inhibited by scavengers  of O~: 
H202, OH., and 102, demonstrating a role for oxidative metabolites in lymphokine- 
induced enhancement of macrophage antimicrobial activity. 
These findings indicate that augmented oxidative metabolism is a consistent marker 
of macrophage activation, and that oxygen intermediates participate in the resistance 
of both in vivo- and in vitro-activated macrophages toward the intracellular parasite, 
72. gondii. 
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